1. Home
  2. TTMI vs NVAX Comparison

TTMI vs NVAX Comparison

Compare TTMI & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TTMI
  • NVAX
  • Stock Information
  • Founded
  • TTMI 1978
  • NVAX 1987
  • Country
  • TTMI United States
  • NVAX United States
  • Employees
  • TTMI N/A
  • NVAX N/A
  • Industry
  • TTMI Electrical Products
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • TTMI Technology
  • NVAX Health Care
  • Exchange
  • TTMI Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • TTMI 2.5B
  • NVAX 2.0B
  • IPO Year
  • TTMI 2000
  • NVAX 1995
  • Fundamental
  • Price
  • TTMI $24.92
  • NVAX $9.01
  • Analyst Decision
  • TTMI Strong Buy
  • NVAX Buy
  • Analyst Count
  • TTMI 4
  • NVAX 6
  • Target Price
  • TTMI $25.31
  • NVAX $17.83
  • AVG Volume (30 Days)
  • TTMI 806.7K
  • NVAX 6.5M
  • Earning Date
  • TTMI 10-30-2024
  • NVAX 11-12-2024
  • Dividend Yield
  • TTMI N/A
  • NVAX N/A
  • EPS Growth
  • TTMI N/A
  • NVAX N/A
  • EPS
  • TTMI 0.66
  • NVAX N/A
  • Revenue
  • TTMI $2,360,827,000.00
  • NVAX $987,667,000.00
  • Revenue This Year
  • TTMI $10.68
  • NVAX N/A
  • Revenue Next Year
  • TTMI $5.46
  • NVAX N/A
  • P/E Ratio
  • TTMI $38.25
  • NVAX N/A
  • Revenue Growth
  • TTMI 3.51
  • NVAX N/A
  • 52 Week Low
  • TTMI $13.43
  • NVAX $3.53
  • 52 Week High
  • TTMI $25.49
  • NVAX $23.86
  • Technical
  • Relative Strength Index (RSI)
  • TTMI 77.29
  • NVAX 34.63
  • Support Level
  • TTMI $19.40
  • NVAX $8.84
  • Resistance Level
  • TTMI $25.47
  • NVAX $9.34
  • Average True Range (ATR)
  • TTMI 0.81
  • NVAX 0.57
  • MACD
  • TTMI 0.51
  • NVAX -0.02
  • Stochastic Oscillator
  • TTMI 91.96
  • NVAX 26.36

About TTMI TTM Technologies Inc.

TTM Technologies Inc manufactures technology solutions, including mission systems, radio frequency (RF) components/RF microwave/microelectronic assemblies, quick-turn and technologically printed circuit boards (PCB). The company is based in the United States and derives roughly half of its revenue domestically. The company organizes itself into two segments: printed circuit boards and RF&S Components. The printed circuit boards segment, which contributes the majority of revenue, offers a range of printed circuit boards as well as layout design and simulation, and testing services. TTM Technologies' products are used in manufacturing, networking, telecommunications, computing, aerospace, and medical fields.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.

Share on Social Networks: